Dosage Form Pipeline

About Navinta

Navinta is a US-based, private generic drug company specializing in complex generics, novel formulations, and API manufacturing. With a foundation in 2003, it has built a portfolio of 16 approved ANDA products, 43 patents, and 36 active Drug Master Files. The company's strategy focuses on difficult-to-make products in areas like analgesics, cardiovascular agents, and cytotoxic anticancer drugs, utilizing both ANDA and NDA pathways. Its operations encompass internal R&D, a DEA-registered facility for controlled substances, and a global network of qualified contract manufacturers.

Therapeutic Areas